IL17A and hepatocellular carcinoma: In conclusion, our results confirmed that IL-17 was generated in large amounts by M2-TAMs distributed in the HCC microenvironment, which suppressed oxaliplatin-induced apoptosis in HCC cells by activating CMA and thus reducing cyclin D1 expression.